Imiglucerase is a man-made form of the naturally-occurring protein beta-glucocerebrosidase. A
deficiency of beta-glucocerebrosidase is called Gaucher disease.
Imiglucerase is used for the treatment of Type 1 Gaucher disease that results in one or more of
the following: anemia (low level of red blood cells), thrombocytopenia (low level of platelets), bone
disease, hepatomegaly (enlargement of the liver), or splenomegaly (enlargement of the spleen).
Imiglucerase may also be used for purposes other than those listed here.
What should I discuss with my healthcare provider before taking imiglucerase?
Before using imiglucerase, tell your doctor if you have
had an allergic reaction to imiglucerase, alglucerase (Ceredase), or
have antibodies to either medication; or
breathing problems or pulmonary hypertension.
You may not be able to use imiglucerase, or you may require a dosage
adjustment or special monitoring during treatment.
Imiglucerase is in the FDA pregnancy category C. This means that it is not known whether
it will be harmful to an unborn baby. Do not use imiglucerase without first talking to your doctor if you
are pregnant or could become pregnant during treatment.
It is not known whether imiglucerase passes into breast milk. Do not use imiglucerase
without first talking to your doctor if you are breast-feeding a baby.
How should I take imiglucerase?
Use imiglucerase exactly as directed by your doctor. If you do not understand these directions,
ask your pharmacist, nurse, or doctor to explain them to you.
Imiglucerase is given by intravenous (into the vein) injection and will most likely be administered
by a healthcare provider.
Your doctor may want you to have blood tests or other medical evaluations during treatment
with imiglucerase to monitor progress and side effects.
Your healthcare provider will store imiglucerase as instructed by the manufacturer. If you are
storing imiglucerase at home, your healthcare provider will give you instructions regarding how to store
the medication.
What happens if I miss a dose of imiglucerase?
Contact your doctor if you miss a dose of imiglucerase.
Where can I get more information about imiglucerase?
Your pharmacist has information about imiglucerase written for health professionals that you may read.
What are the possible side effects of imiglucerase?
Symptoms of allergic reactions including difficulty breathing; closing of the throat; swelling of
the lips, tongue, or face; hives; itching; flushing; and dizziness or fainting, have occurred with the use of
imiglucerase. Approximately 15% of patients treated with imiglucerase develop antibodies to
imiglucerase. Approximately 46% of patients with detectable antibodies have experienced an allergic
reaction. Emergency medical attention may be required if an allergic reaction is experienced.
Talk to your doctor if you experience any of the following less serious side effects:
discomfort, burning, itching, swelling, or abscess (open wound or
sore) at the injection site;
nausea or vomiting;
abdominal pain;
diarrhea;
fatigue;
headache;
dizziness; or
rash.
Side effects other than those listed here may also occur. Talk to your doctor
about any side effect that seems unusual or that is especially bothersome. You may report side effects to FDA at 1-800-FDA-1088.
What is the most important information I should know about imiglucerase?
Symptoms of allergic reactions including difficulty breathing; closing of the throat; swelling of
the lips, tongue, or face; hives; itching; flushing; and dizziness or fainting, have occurred with the use of
imiglucerase. Approximately 15% of patients treated with imiglucerase develop antibodies to
imiglucerase. Approximately 46% of patients with detectable antibodies have experienced an allergic
reaction. Emergency medical attention may be required if an allergic reaction is experienced.
What should I avoid while taking imiglucerase?
There are no restrictions on food, beverages, or activity during treatment with imiglucerase.
What other drugs will affect imiglucerase?
Imiglucerase is not expected to interact with other medications. Talk to your doctor or
pharmacist before taking other prescription or over-the-counter medications, including herbal products,
during treatment with imiglucerase.
What happens if I have an overdose of imiglucerase?
Remember, keep this and all other medicines out of the reach of children, never share
your medicines with others, and use this medication only for the indication prescribed.
Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate,
up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum
information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not
warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does
not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist
licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not
a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or
drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any
given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information
Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug
interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse
or pharmacist.
Content provided by Multum - Last Updated 11/10/2009